Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2019
Durability of Spontaneous and Treatment-Related Loss of Hepatitis B s AntigenAhmad Samer Alawad, Sungyoung Auh, Daniel Suarez, et al.
Hepatology (Baltimore, Md.)|August 2, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|June 16, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
Case Reports in Hepatology|August 22, 2025
Autoimmune-Like Hepatitis Following Hepatic Graft-Versus-Host Disease in an Allogenic Hematopoietic Cell Transplant RecipientHarish Gopalakrishna, David E Kleiner, Jennifer A Kanakry, et al.
Gastroenterology|August 7, 2013
The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunityJens M Werner, Adil Abdalla, Naveen Gara, et al.
Hepatology (Baltimore, Md.)|March 31, 2009
Diagnosis, management, and treatment of hepatitis C: an updateMarc G Ghany, Doris B Strader, David L Thomas, et al.
Hepatology (Baltimore, Md.)|July 18, 2017
NAM 2017 report: A national plan to eliminate hepatitis B and C in the United States by 2030 and the AASLD's responseHugo R Rosen, Marc G Ghany, Raymond T Chung, et al.
ACG Case Reports Journal|June 1, 2026
Drug-Induced Liver Injury From a Novel Antifungal - OlorofimShaun T Ranade, Disha Sharma, Gian Rodriguez Franco, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Spontaneous Clearance of Drug-Resistant Chronic Hepatitis C Virus InfectionChunwei W Lai, Akira Nishio, Sharika Hasan, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2022
Letter: systematic review with meta-analysis on the impact of functional cure on clinical outcomes in patients with chronic hepatitis B-authors' replyAnusha Vittal, Disha Sharma, Alvin Hu, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2019
Durability of Spontaneous and Treatment-Related Loss of Hepatitis B s AntigenAhmad Samer Alawad, Sungyoung Auh, Daniel Suarez, et al.
Hepatology (Baltimore, Md.)|August 2, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|June 16, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
Case Reports in Hepatology|August 22, 2025
Autoimmune-Like Hepatitis Following Hepatic Graft-Versus-Host Disease in an Allogenic Hematopoietic Cell Transplant RecipientHarish Gopalakrishna, David E Kleiner, Jennifer A Kanakry, et al.
Gastroenterology|August 7, 2013
The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunityJens M Werner, Adil Abdalla, Naveen Gara, et al.
Hepatology (Baltimore, Md.)|March 31, 2009
Diagnosis, management, and treatment of hepatitis C: an updateMarc G Ghany, Doris B Strader, David L Thomas, et al.
Hepatology (Baltimore, Md.)|July 18, 2017
NAM 2017 report: A national plan to eliminate hepatitis B and C in the United States by 2030 and the AASLD's responseHugo R Rosen, Marc G Ghany, Raymond T Chung, et al.
ACG Case Reports Journal|June 1, 2026
Drug-Induced Liver Injury From a Novel Antifungal - OlorofimShaun T Ranade, Disha Sharma, Gian Rodriguez Franco, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Spontaneous Clearance of Drug-Resistant Chronic Hepatitis C Virus InfectionChunwei W Lai, Akira Nishio, Sharika Hasan, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2022
Letter: systematic review with meta-analysis on the impact of functional cure on clinical outcomes in patients with chronic hepatitis B-authors' replyAnusha Vittal, Disha Sharma, Alvin Hu, et al.
Pageof 19